Harvard Business Review

NOVEMBER 11, 2013

Health care systems are transforming themselves to deliver the “Triple Aim” of providing better care and a better patient experience, improving the health of populations, and lowering the cost of care. Mayo was the first care-delivery group to receive this delegated authority. Authority and Structure.

Quality 8

Quality Mayo System Six Sigma 8

Harvard Business Review

SEPTEMBER 12, 2012

Since companies test their own products—an obvious conflict of interest—they naturally design clinical trials to maximize evidence that they are beneficial and minimize evidence they are harmful. See The Risks of Prescription Drugs (Columbia 2010). These cost employers even more in hidden ways.

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

FEBRUARY 3, 2017

The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1% Ethical conduct is particularly important in emerging markets where companies rely heavily on governments’ goodwill for market access and health care investments. Enhance corporate reputations.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8

Harvard Business Review

MARCH 2, 2017

On February 3 President Trump issued an executive order directing the Treasury Department to conduct a sweeping review of financial regulation, including Dodd-Frank , the financial reform bill passed, in 2010, as part of the Obama administration’s response to the 2008 financial crisis and subsequent recession.

Banking 8

Banking Crisis System Compliance 8